Trans-Tranilast
Trans-Tranilast is a small molecule antiallergic agent approved for bronchial asthma and later for keloids and hypertrophic scars. It is utilized in research on allergic diseases like atopic dermatitis and rhinitis, with studies demonstrating its modulatory effects in both in vivo and in vitro experimental models.
Product Specifications
CAS Number
70806-55-2
Product Name Alternative
Angiotensin Receptor, inhibit, Inhibitor, trans-SB 252218, TransTranilast, trans-Tranilast, Trans-Tranilast, Trans Tranilast, Tranilast trans-
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
≥95% (May vary between batches)
Solubility
DMSO:60 mg/mL (183.3 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.11 mM)
Smiles
N (C (/C=C/C1=CC (OC) =C (OC) C=C1) =O) C2=C (C (O) =O) C=CC=C2
Molecular Formula
C18H17NO5
Molecular Weight
327.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human CCKBR sgRNA gene knockout kit - Lentiviral human CCKBR sgRNA gene knockout kit (plasmid)
FOXP1 (Forkhead Box P1, QRF1, 12CC4, hFKH1B, HSPC215) (HRP)
FOXP1 (Forkhead Box P1, QRF1, 12CC4, hFKH1B, HSPC215) (HRP)
GADD45A sgRNA CRISPR Lentivector (Human) (Target 3)
THOC4, ID (ALYREF, ALY, BEF, THOC4, THO complex subunit 4, Ally of AML-1 and LEF-1, Aly/REF export factor, Transcriptional coactivator Aly/REF, bZIP-enhancing factor BEF) (MaxLight 550) discontinued
